Restoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells.

Restoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells.
复制标题

DOI:
10.1016/j.canlet.2015.03.042
复制
发表时间:
2015-07-01
期刊:
影响因子:
9.7
通讯作者:
Falzon, Miriam
Falzon, Miriam
中科院分区:
医学1区
文献类型:
--
作者:
Bhatia, Vandanajay;Falzon, Miriam

文献摘要

参考文献

被引文献

相似文献

结直肠癌(CRC)是发达国家第三大常见癌症。大部分病例与慢性肠道炎症有关,伴随TNF-α释放增加和Snail 1/Snail 2水平升高。这些转录因子反过来又抑制维生素D受体(VDR)的表达,导致对1,25-二羟基维生素D(1,25 D)的保护性抗增殖和抗迁移作用的反应性丧失。实验和流行病学证据支持使用天然产品来靶向CRC。在此,我们发现黄酮木脂素水飞蓟宾逆转了TNF-α诱导的1,25 D耐药人结肠癌细胞HT-29中Snail 1和Snail 2的上调。这些水飞蓟宾效应伴随着VDR水平的增加; Snail 1过表达逆转了这些水飞蓟宾效应。水飞蓟宾也恢复启动子活性的维生素D反应元件(VDRE)报告构建体。虽然1,25 D对HT-29和SW 480-R细胞的增殖和迁移没有显著影响,但与水飞蓟宾共同处理恢复了1,25 D的反应性。此外,与水飞蓟宾加1,25 D的共同治疗在单独的水飞蓟宾没有效果的剂量下降低了增殖和迁移。这些发现表明,这种组合可能提供了一种新的方法来靶向慢性结肠炎症条件下的CRC。
Colorectal carcinoma (CRC) is the third most common cancer in developed countries. A large fraction of cases are linked to chronic intestinal inflammation, with concomitant increased TNF-α release and elevated Snail1/Snail2 levels. These transcription factors in turn suppress vitamin D receptor (VDR) expression, resulting in loss of responsiveness to the protective anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D (1,25D). Experimental and epidemiologic evidence support the use of natural products to target CRC. Here we show that the flavonolignan silibinin reverses the TNF-α-induced upregulation of Snail1 and Snail2 in the 1,25D-resistant human colon carcinoma cells HT-29. These silibinin effects are accompanied by an increase in VDR levels; Snail1 overexpression reverses these silibinin effects. Silibinin also restores promoter activity from a vitamin D-response element (VDRE) reporter construct. While 1,25D had no significant effect on HT-29 and SW480-R cell proliferation and migration, co-treatment with silibinin restored 1,25D responsiveness. In addition, co-treatment with silibinin plus 1,25D decreased proliferation and migration at doses where silibinin alone had no effect. These findings demonstrate that this combination may present a novel approach to target CRC in conditions of chronic colonic inflammation.
DOI: 10.4161/cbt.11.3.14098
发表时间: 2011-02-01
影响因子: 3.6
作者:
Bobilev, Irene;Novik, Victoria;Danilenko, Michael
通讯作者: Danilenko, Michael
DOI: 10.3390/ijms13021632
发表时间: 2012
影响因子: 5.6
作者:
Bezdekova M;Brychtova S;Sedlakova E;Langova K;Brychta T;Belej K
通讯作者: Belej K
DOI: 10.1093/carcin/22.9.1429
发表时间: 2001-09-01
期刊: CARCINOGENESIS
影响因子: 4.7
作者:
Kallay, E;Pietschmann, P;Cross, HS
通讯作者: Cross, HS
DOI: 10.1038/sj.onc.1205240
发表时间: 2002-03-07
期刊: ONCOGENE
影响因子: 8
作者:
Dhanalakshmi, S;Singh, RP;Agarwal, R
通讯作者: Agarwal, R
DOI: 10.1369/jhc.2009.954339
发表时间: 2010-03-01
影响因子: 3.2
作者:
Horvath, Henrik C.;Lakatos, Peter;Kallay, Enikoe
通讯作者: Kallay, Enikoe